Press Coverage

You are here


The work by CBSSM's Sarah Hawley and Reshma Jagsi were recently highlighted by Michigan Medicine. Sarah Hawley focuses her research on improving the quality of cancer care through analyzing data and speaking with cancer patients about their experiences to enhance decision making. Her current project is an R01 study in collaboration with CBSSM Director, Reshma Jagsi is evaluating the efficacy of shared decision engagement systems — addressing patient emotion and “circling back” with clinicians — in the treatment of breast cancer.


CBSSM's Melissa Creary was recently interviewed for Stateside Radio about the unintended consequences of reporting race variables associated with COVID-19 data.

Research Topics: 

CBSSM's Kayte Spector-Bagdady was one of the speakers at the Wall Street Journal’s (virtual) Health Forum, which convened March 24. The WSJ’s interactive virtual event—originally scheduled to take place in person—explored this COVID-19 pandemic and much more. Spector-Bagdady spoke about research ethics during public health emergencies and about genetic data privacy.


CBSSM's Kayte Spector-Bagdady recently wrote an opinion piece in USA Today focusing on the secondary use of research data and specimens. In this piece, she defends the choice of University of Washington researchers to re-purpose flu swabs for COVID19 testing despite government opposition. The full article can be found below.


Many breast cancer patients wrongly believe that having both breasts removed — a double mastectomy — will improve their chance of survival, one study has found. “Our finding that so many women are receiving much more extensive surgery than needed to treat their disease is striking,” said study lead author Dr. Reshma Jagsi. Researchers surveyed more than 1,900 women treated for breast cancer and found that nearly half of them had considered having a double mastectomy. Many who had the more aggressive surgery had no risk factors, such as family history of breast cancer, that would increase their odds for cancer in the second breast.